Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-13

Clinical Trial Update: Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver Disease [NA]

View source ↗

Summary

This is a completed clinical trial evaluating phlebotomy as a treatment for non-alcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Western Ontario, Canada | Conditions: Non-alcoholic Fatty Liver Disease | NA | Status: COMPLETED